NM_005431.2:c.678T>G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_005431.2(XRCC2):c.678T>G(p.Tyr226*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005431.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XRCC2 | NM_005431.2 | c.678T>G | p.Tyr226* | stop_gained | Exon 3 of 3 | ENST00000359321.2 | NP_005422.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XRCC2 | ENST00000359321.2 | c.678T>G | p.Tyr226* | stop_gained | Exon 3 of 3 | 1 | NM_005431.2 | ENSP00000352271.1 | ||
XRCC2 | ENST00000495707.1 | n.700T>G | non_coding_transcript_exon_variant | Exon 3 of 3 | 1 | |||||
XRCC2 | ENST00000698506.1 | c.510T>G | p.Tyr170* | stop_gained | Exon 2 of 2 | ENSP00000513758.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461864Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727230
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74342
ClinVar
Submissions by phenotype
not provided Uncertain:2
This variant has not been reported in the literature in individuals with XRCC2-related disease. ClinVar contains an entry for this variant (Variation ID: 182998). This sequence change results in a premature translational stop signal in the XRCC2 gene (p.Tyr226*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 55 amino acids of the XRCC2 protein. This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant is denoted XRCC2 c.678T>G at the cDNA level and p.Tyr226Ter (Y226X) at the protein level. The substitution creates a nonsense variant, which changes a Tyrosine to a premature stop codon (TAT>TAG) in the last exon of the gene, exon 3. This mutation results in the loss of the last 55 amino acids of the protein for which the clinical significance is unknown. This variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. The lost region is not within any known functional domain and no mutations, to our knowledge, have been reported in the lost region. Based on the currently available information, we consider Tyr226Ter to be a variant of uncertain significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.Y226* variant (also known as c.678T>G), located in coding exon 3 of the XRCC2 gene, results from a T to G substitution at nucleotide position 678. This changes the amino acid from a tyrosine to a stop codon within coding exon 3. This alteration occurs at the 3' terminus of the XRCC2 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 55 amino acids of the protein. The exact functional effect of this alteration is unknown. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at